![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Pythagoras Earns CE Mark for Mapping Device to Treat Resistant Hypertension
Pythagoras Earns CE Mark for Mapping Device to Treat Resistant Hypertension
March 27, 2018
Pythagoras Medical earned a CE Mark for its ConfidenHT nerve mapping technology, designed to verify the effectiveness of a denervation procedure that can restore normal blood pressure in many patients.
The mapping catheter stimulates different areas of the renal artery to map out “hot spots” for ablation while reducing the risk factor of unnecessary ablation.
By mapping out the renal artery’s hot spots, the device helps physicians to determine the effectiveness of the renal denervation procedure.
Upcoming Events
-
21Oct